Morning Overview on MSN

Stem-cell edits may program the immune system to make therapeutic proteins

For the roughly 30,000 Americans living with hemophilia and thousands more with rare enzyme deficiencies, treatment often ...
Geeky Gadgets

Master Excel Collaboration with Allow Edit Ranges : Protect and Assign Cell Editing

Have you ever found yourself in a chaotic Excel workbook, where multiple people are editing the same cells, accidentally overwriting each other’s work, or making unintended changes? It’s frustrating, ...
Seeking Alpha

Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress

Robust efficacy data: ≥90% LDL-C reduction in non-human primates achieved within 48 hours of a single dose of EDIT-401; ≥90% LDL-C reduction in mice with high baseline LDL-C and reduced LDLR function ...
Business Insider

Editas Medicine Announces In Vivo Proof-of-Concept Data for EDIT-301, in Development for the Treatment of Sickle Cell Disease and Beta-Thalassemia

CAMBRIDGE, Mass., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced in vivo proof-of-concept data supporting the development of ...
Seeking Alpha

Editas Medicine Announces Clinical Achievements in the Development of EDIT-301 for Sickle Cell Disease

CAMBRIDGE, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (EDIT), a leading genome editing company, today announced the dosing and confirmed successful neutrophil and platelet ...
ksn.com

Editas Medicine Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EDIT-301 for the Treatment of Severe Sickle Cell Disease

CAMBRIDGE, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that the U.S. Food and Drug Administration (FDA) ...